Patel Dinesh V PH D's Form 4 filing
Protagonist Therapeutics, IncPTGX · filed Jan 27, 2026
- Accession no.
- 0001104659-26-007129
- Filed
- Jan 27, 2026
- Trade date
- Jan 23-27, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 4 derivative transactions. Open-market sales total $4.06M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel Dinesh V PH DCIK 0001120477 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Common Stock | GGiftDisposed | −6,000 | $0.00 | $0 | 574,505 | Direct | |
| Jan 23, 2026 | Common Stock | MOption exerciseAcquired | +19,315 | $4.21 | +$81,316.15 | 593,820 | Direct | |
| Jan 23, 2026 | Common Stock | SSaleDisposed | −19,315 | $84.59F2 | −$1,633,855.85 | 574,505 | Direct | |
| Jan 26, 2026 | Common Stock | MOption exerciseAcquired | +10,685 | $4.21 | +$44,983.85 | 585,190 | Direct | |
| Jan 26, 2026 | Common Stock | SSaleDisposed | −10,685 | $84.00F3 | −$897,540 | 574,505 | Direct | |
| Jan 26, 2026 | Common Stock | MOption exerciseAcquired | +14,205 | $21.58 | +$306,543.9 | 588,710 | Direct | |
| Jan 26, 2026 | Common Stock | SSaleDisposed | −14,205 | $84.05F4 | −$1,193,930.25 | 574,505 | Direct | |
| Jan 27, 2026 | Common Stock | MOption exerciseAcquired | +4,068 | $21.58 | +$87,787.44 | 578,573 | Direct | |
| Jan 27, 2026 | Common Stock | SSaleDisposed | −4,068 | $83.19F5 | −$338,416.92 | 574,505 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Common Stock | MOption exerciseDisposed | −19,315 | $0.00 | $0 | 10,685 | Direct | |
| Jan 26, 2026 | Common Stock | MOption exerciseDisposed | −10,685 | $0.00 | $0 | 0 | Direct | |
| Jan 26, 2026 | Common Stock | MOption exerciseDisposed | −14,205 | $0.00 | $0 | 304,068 | Direct | |
| Jan 27, 2026 | Common Stock | MOption exerciseDisposed | −4,068 | $0.00 | $0 | 300,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $84.41 to $84.64. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $84 to $84.095. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $84 to $84.075. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $83.06 to $83.59. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.